Trial Profile
Blood Donor CVD 9000: Collection of Blood for In Vitro Studies From Healthy Adults Who Have Received Oral Cholera Vaccine (CVD 103-HgR)
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 07 Feb 2023
Price :
$35
*
At a glance
- Drugs PXVX 0200 (Primary)
- Indications Cholera
- Focus Therapeutic Use
- 04 Mar 2022 Status changed from recruiting to discontinued.
- 06 Dec 2018 Status changed from not yet recruiting to recruiting.
- 06 Nov 2018 New trial record